Hideyuki Eguchi

1.6k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Hideyuki Eguchi is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Hideyuki Eguchi has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Epidemiology. Recurrent topics in Hideyuki Eguchi's work include Metabolism, Diabetes, and Cancer (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Hideyuki Eguchi is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Hideyuki Eguchi collaborates with scholars based in Japan and United States. Hideyuki Eguchi's co-authors include Akira Sekikawa, Hideo Manaka, Takeo Kato, Kazuhiko Igarashi, Masato Tominaga, Makoto Tominaga, Hideo Sasaki, Masahiko Igarashi, Hiroshi Ohnuma and H Fukuyama and has published in prestigious journals such as Diabetes Care, International Journal of Epidemiology and Transplantation.

In The Last Decade

Hideyuki Eguchi

17 papers receiving 1.2k citations

Hit Papers

Impaired glucose tolerance is a risk factor for cardiovas... 1999 2026 2008 2017 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
    1999 918 citations Masato Tominaga, Hideyuki Eguchi et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideyuki Eguchi Japan 9 896 353 242 225 203 17 1.3k
R.J. Heine Netherlands 22 920 1.0× 363 1.0× 256 1.1× 310 1.4× 246 1.2× 40 1.6k
Mark Stolar United States 16 1.1k 1.2× 367 1.0× 169 0.7× 181 0.8× 107 0.5× 23 1.4k
Angela Doering Germany 17 503 0.6× 253 0.7× 432 1.8× 267 1.2× 183 0.9× 25 1.4k
Nicolae Hâncu Romania 18 696 0.8× 179 0.5× 130 0.5× 121 0.5× 238 1.2× 54 1.1k
Gerard T. Chew Australia 16 524 0.6× 320 0.9× 162 0.7× 176 0.8× 150 0.7× 23 1.2k
Katia Bonomo Italy 12 693 0.8× 209 0.6× 209 0.9× 222 1.0× 130 0.6× 17 1.1k
H Schmechel Germany 8 796 0.9× 249 0.7× 175 0.7× 132 0.6× 69 0.3× 17 1.1k
Ernst J. Schaefer United States 19 540 0.6× 253 0.7× 203 0.8× 165 0.7× 150 0.7× 22 1.2k
Yasuyuki Tsujita Japan 19 384 0.4× 268 0.8× 446 1.8× 161 0.7× 119 0.6× 39 1.1k
Katsuya Yamazaki Japan 18 471 0.5× 248 0.7× 162 0.7× 206 0.9× 276 1.4× 49 1.2k

Countries citing papers authored by Hideyuki Eguchi

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Eguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Eguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Eguchi more than expected).

Fields of papers citing papers by Hideyuki Eguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Eguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Eguchi. The network helps show where Hideyuki Eguchi may publish in the future.

Co-authorship network of co-authors of Hideyuki Eguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Eguchi. A scholar is included among the top collaborators of Hideyuki Eguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Eguchi. Hideyuki Eguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tanemura, Masahiro, Yu Ohmura, T Machida, et al.. (2010). IN VITRO AND IN VIVO OVER-INDUCTION OF AUTOPHAGY IN PANCREATIC ISLETS BY RAPAMYCIN AND IMPAIRS ISLET FUNCTION. Transplantation. 90. 372–372. 1 indexed citations
2.
Saitoh, Tamotsu, Wataru Kameda, Hiroshi Yamaguchi, et al.. (2003). Hyperintense hippocampus on diffusion-weighted MR images in a case of insulinoma with persistent memory disturbance.. Nihon Naika Gakkai Zasshi. 92(1). 137–139. 4 indexed citations
3.
Saitoh, Tamotsu, Makoto Daimon, Hideyuki Eguchi, et al.. (2002). Type 2 Diabetes is Not a Risk Factor for Asymptomatic Ischemic Brain Lesion-The Funagata Study.. Internal Medicine. 41(5). 351–356. 6 indexed citations
4.
Oizumi, Toshihide, Makoto Daimon, Tamotsu Saitoh, et al.. (2001). Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg Polymorphism of the β3-Adrenergic Receptor Is Associated With Type 2 Diabetes and Obesity in a Large Japanese Sample. Diabetes Care. 24(9). 1579–1583. 63 indexed citations
5.
Sekikawa, Akira, Hideyuki Eguchi, Makoto Tominaga, et al.. (2000). Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan. Journal of Diabetes and its Complications. 14(2). 78–83. 51 indexed citations
6.
Daimon, Makoto, Shinji Susa, Hiroshi Yamaguchi, et al.. (2000). Increase in Serum Ceruloplasmin with Aging is not Observed in Type 2 Diabetes.. Endocrine Journal. 47(3). 215–219. 4 indexed citations
7.
Sekikawa, Akira, Hideyuki Eguchi, Makoto Tominaga, et al.. (1999). Evaluating the reported prevalence of type 2 diabetes mellitus by the Oguni diabetes registry using a two-sample method of capture-recapture. International Journal of Epidemiology. 28(3). 498–501. 3 indexed citations
8.
Sekikawa, Akira, Hideyuki Eguchi, Makoto Tominaga, et al.. (1999). Waist to Hip Ratio, Body Mass Index, and Glucose Intolerance from Funagata Population-Based Diabetes Survey in Japan.. The Tohoku Journal of Experimental Medicine. 189(1). 11–20. 8 indexed citations
9.
Tominaga, Masato, Hideyuki Eguchi, Hideo Manaka, et al.. (1999). Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.. Diabetes Care. 22(6). 920–924. 918 indexed citations breakdown →
10.
Okamoto, Kensaku, Hirotoshi Tanaka, Yuichi Makino, et al.. (1998). Redox-dependent regulation of intracellular trafficking of the glucocorticoid receptor. Pathophysiology. 5. 93–93. 1 indexed citations
11.
Yamasaki, Yoshimitsu, Ryuzo Kawamori, Taro Wasada, et al.. (1997). Pioglitazone (AD-4833) Ameliorates Insulin Resistance in Patients with NIDDM. The Tohoku Journal of Experimental Medicine. 183(3). 173–183. 64 indexed citations
12.
Tominaga, Makoto, Kazuhiko Sugiyama, Takashi Abe, et al.. (1995). Effects of Seishin-renshi-in and Gymnema sylvestre on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice. 29(1). 11–17. 29 indexed citations
13.
Tominaga, Makoto, Keiichi Yamatani, Masahiko Igarashi, et al.. (1995). Insulin-Like Growth Factor I Resistance in Peripheral Tissue but not in Liver in Streptozotocin-Induced Diabetic Rats.. Endocrine Journal. 42(3). 397–403. 3 indexed citations
14.
Sekikawa, Akira, Makoto Tominaga, Kenji Takahashi, et al.. (1993). Prevalence of Diabetes and Impaired Glucose Tolerance in Funagata Area, Japan. Diabetes Care. 16(4). 570–574. 68 indexed citations
15.
Tominaga, Makoto, Masahiko Igarashi, Makoto Daimon, et al.. (1993). Thiazolidinediones (AD-4833 and CS-045) Improve Hepatic Insulin Resistance in Streptozotocin-Induced Diabetic Rats.. Endocrine Journal. 40(3). 343–349. 38 indexed citations
16.
Tominaga, Makoto, Mitsuo Matsumoto, M. Igarashi, et al.. (1992). Insulin antibody does not cause insulin resistance during glucose clamping in rats. Diabetes Research and Clinical Practice. 18(3). 143–151. 8 indexed citations
17.
Takahashi, Hideo, Hideo Manaka, Akira Sekikawa, et al.. (1991). Hyperglycaemia but not hyperinsulinaemia prevents the secretion of glucagon-like peptide-1 (7-36 amide) stimulated by fat ingestion. Scandinavian Journal of Clinical and Laboratory Investigation. 51(6). 499–507. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.J. Heine Breakdown of academic impact, for papers by Mark Stolar Breakdown of academic impact, for papers by Angela Doering Breakdown of academic impact, for papers by Nicolae Hâncu Breakdown of academic impact, for papers by Gerard T. Chew Breakdown of academic impact, for papers by Katia Bonomo Breakdown of academic impact, for papers by H Schmechel Breakdown of academic impact, for papers by Ernst J. Schaefer Breakdown of academic impact, for papers by Yasuyuki Tsujita Breakdown of academic impact, for papers by Katsuya Yamazaki
Rankless by CCL
2026